Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v2.4.0.6
Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2011
Revenue $ 40,044 $ 69,655 $ 147,849
Cost of goods sold 25,720 46,398 106,297
Gross profit 14,324 23,257 41,552
Operating expenses:      
Sales and marketing 7,439 6,496 10,813
Research and development 7,326 7,727 11,774
General and administrative 9,910 7,615 8,623
Intangible amortization 892 548 545
Restructuring 149 550 0
Goodwill impairment 2,884    
Total operating expenses 28,600 22,936 31,755
Operating income (loss) (14,276) 321 9,797
Gain on CNS asset sale   31,654  
Other income (expense), net 175 331 20
Income (loss) before income taxes and discontinued operations (14,101) 32,306 9,817
Income tax (expense) benefit (29,392) (12,875) 53,304
Net income (loss) from continuing operations (43,493) 19,431 63,121
Discontinued operations (Note 1):      
Gain on sale of discontinued operations, net of tax expense of $12,359   20,489  
Income (loss) from discontinued operations, net of tax benefit (expense) of $813, $(1,447) and $(53) for fiscal years 2013, 2012 and 2011, respectively (545) 2,062 4,815
Net income (loss) $ (44,038) $ 41,982 $ 67,936
Basic net income (loss) per share:      
Basic net income (loss) from continuing operations $ (0.73) $ 0.29 $ 0.93
Basic net income (loss) from discontinued operations $ (0.01) $ 0.34 $ 0.07
Basic net income (loss) per share $ (0.73) [1] $ 0.63 $ 1.00
Diluted net income (loss) per share:      
Diluted net income (loss) from continuing operations $ (0.73) $ 0.29 $ 0.91
Diluted net income (loss) from discontinued operations $ (0.01) $ 0.33 $ 0.07
Diluted net income (loss) per share $ (0.73) [1] $ 0.62 $ 0.98
Weighted-average number of Common shares outstanding:      
Basic 59,944 66,657 67,848
Effect of dilutive securities: restricted stock, restricted stock units, performance stock units and stock options 0 [2] 1,322 [2] 1,629 [2]
Diluted 59,944 67,979 69,477
[1] *Per share amounts may not sum to totals because of rounding.
[2] ** In periods with a net loss, the basic loss per share equals the diluted loss per share as all common stock equivalents are excluded from the per share calculation. The Company had 1.2 million and 2.4 million options outstanding as of March 31, 2012 and 2011, respectively, which were not included in the computation of average diluted shares outstanding because they were anti-dilutive.